We are live on
!
Find out more
DHFB
Dixon Hubard Feinour & Brown Portfolio holdings
AUM
$842M
1-Year Est. Return
2.74%
This Fund
S&P 500
This Quarter
Est. Return
+24%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
–
AUM
$385M
AUM Growth
+$89.8M
(+30%)
Cap. Flow
+$11.6M
Cap. Flow
% of AUM
3.02%
Top 10 Holdings %
Top 10 Hldgs %
35.04%
Holding
192
New
25
Increased
41
Reduced
78
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Veeva Systems
VEEV
|
+$6.61M |
| 2 |
Netflix
NFLX
|
+$6.39M |
| 3 |
AbbVie
ABBV
|
+$6.08M |
| 4 |
Abbott
ABT
|
+$5.42M |
| 5 |
Akamai
AKAM
|
+$5.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
L3Harris
LHX
|
+$6.27M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$5.9M |
| 3 |
JPMorgan Chase
JPM
|
+$5.57M |
| 4 |
Comcast
CMCSA
|
+$4.85M |
| 5 |
Copart
CPRT
|
+$4.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.25% |
| 2 | Technology | 22.34% |
| 3 | Consumer Discretionary | 11.07% |
| 4 | Communication Services | 9.13% |
| 5 | Consumer Staples | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.99T
| $24.7M | 6.4% |
264,496
-1,824
| -0.7% | -$141K |
|
2
Microsoft
MSFT
$2.92T
| $21.3M | 5.52% |
105,404
+3,463
| +3% | +$629K |
|
3
Thermo Fisher Scientific
TMO
$214B
| $13.2M | 3.43% |
32,437
-619
| -2% | -$207K |
|
4
Adobe
ADBE
$99.1B
| $12.5M | 3.25% |
28,991
-501
| -2% | -$186K |
|
5
Dollar General
DG
$27.8B
| $11.6M | 3.01% |
61,131
-1,580
| -3% | -$286K |
|
6
Zoetis
ZTS
$32.5B
| $11.6M | 3% |
79,283
-3,482
| -4% | -$455K |
|
7
lululemon athletica
LULU
$13.7B
| $11.1M | 2.88% |
34,425
-1,317
| -4% | -$337K |
|
8
Home Depot
HD
$344B
| $10.1M | 2.61% |
37,912
-730
| -2% | -$167K |
|
9
Edwards Lifesciences
EW
$48.2B
| $9.79M | 2.54% |
126,489
-6,192
| -5% | -$440K |
|
10
Amazon
AMZN
$2.48T
| $9.21M | 2.39% |
61,400
+2,340
| +4% | +$283K |
|
11
Medpace
MEDP
$15.9B
| $8.73M | 2.27% |
71,500
-2,015
| -3% | -$171K |
|
12
Alphabet (Google) Class C
GOOG
$4.07T
| $8.58M | 2.23% |
114,360
-1,940
| -2% | -$131K |
|
13
Verizon
VZ
$201B
| $8.53M | 2.21% |
148,340
-2,072
| -1% | -$117K |
|
|
14
Veeva Systems
VEEV
$32.7B
| $8.36M | 2.17% |
+33,309
| New | +$6.61M |
|
15
Teradyne
TER
$50.3B
| $7.74M | 2.01% |
88,978
-1,400
| -2% | -$93.8K |
|
16
Alibaba
BABA
$276B
| $7.57M | 1.96% |
30,384
+2,074
| +7% | +$432K |
|
|
17
Netflix
NFLX
$301B
| $7.34M | 1.9% |
+150,210
| New | +$6.39M |
|
|
18
AbbVie
ABBV
$465B
| $7.33M | 1.9% |
75,737
+69,032
| +1,030% | +$6.08M |
|
19
MSCI
MSCI
$42.1B
| $7.03M | 1.82% |
18,686
-215
| -1% | -$69.5K |
|
|
20
Abbott
ABT
$187B
| $6.78M | 1.76% |
67,914
+59,950
| +753% | +$5.42M |
|
21
Estee Lauder
EL
$30.7B
| $6.68M | 1.73% |
34,695
-335
| -1% | -$59.9K |
|
|
22
Alphabet (Google) Class A
GOOGL
$4.08T
| $6.29M | 1.63% |
83,600
+560
| +0.7% | +$37.8K |
|
23
Johnson & Johnson
JNJ
$643B
| $6.25M | 1.62% |
42,552
+1,484
| +4% | +$216K |
|
|
24
Akamai
AKAM
$16.2B
| $5.9M | 1.53% |
+52,645
| New | +$5.29M |
|
25
Pfizer
PFE
$144B
| $5.82M | 1.51% |
157,076
+10,276
| +7% | +$349K |
|
Similar funds
BDWM
MCM
TFM
MWM
CP
BWM
FPS
IC
Dixon Hubard Feinour & Brown's Q2 2020 Portfolio in Review
As of Q2 2020, Dixon Hubard Feinour & Brown held 192 positions worth $385M, up 30% from $296M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Dixon Hubard Feinour & Brown deployed $11.6M of net new capital in Q2 2020, opening 25 new positions and adding to 41 existing holdings. Its largest new stake was Veeva Systems: 33,309 shares worth $8.36M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard FTSE Emerging Markets ETF, an estimated $5.9M trimmed.
- Dixon Hubard Feinour & Brown's largest Q2 2020 buy was Veeva Systems: 33,309 shares worth $8.36M.
- Dixon Hubard Feinour & Brown added most to AbbVie in Q2 2020, an estimated $6.08M increase.
- Dixon Hubard Feinour & Brown's biggest Q2 2020 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $5.9M.
- Dixon Hubard Feinour & Brown fully exited L3Harris in Q2 2020, selling an estimated $6.27M.
- Dixon Hubard Feinour & Brown's ten largest holdings make up 35% of its $385M portfolio in Q2 2020.
- Dixon Hubard Feinour & Brown opened 25 new positions and closed 6 in Q2 2020.
- Dixon Hubard Feinour & Brown's portfolio value rose 30% quarter-over-quarter to $385M.
Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2020, filed 31 Jul 2020.